Hangzhou Nutrition Biotechnology Co., Ltd. TC
Hangzhou Nutrition Biotechnology Co., Ltd. is a veterinary-safe, biotechnical enterprise based in Hangzhou, China. The company describes itself as a reputable exporter within the biotechnical industry, with an annual production capacity rated at 500 tons. Its core activities revolve around the development and production of collagen products and enteral nutrition (EN) formulas intended for global markets. The business emphasizes its strong emphasis on research and development, highlighting a dedicated R&D department with extensive experience in the sector.
Historically, the company traces a notable milestone to 2012 when its fish collagen peptide technology was recognized and supported by the Zhejiang Province government as a key project. This recognition underscores a level of state-backed interest in the company’s collagen-related capabilities and technology. Hangzhou Nutrition Biotechnology Co., Ltd. operates its own production workshops dedicated to collagen and related products, with stated annual outputs of 500 tons for fish collagen powder and 300 tons for EN products. The product portfolio includes bulk hydrolyzed collagen powder, fish collagen peptide, and collagen granules, as well as various enteral nutrition powders that cover formulations such as mixed branched-chain amino acids, dietary fiber, and mixed vitamins.
Quality assurance appears to be a priority for the company, as evidenced by the attainment of multiple certifications. The organization reports compliance with QS (Quality System), HACCP (Hazard Analysis and Critical Control Points), ISO 22000 (Food Safety Management), HALAL, and CIQ (China Inspection and Quarantine). These certifications align with international food safety and quality standards and may facilitate entry into global markets that require demonstrable product safety and traceability. The company also notes that it provides original equipment manufacturer (OEM) services for a variety of fish collagen products across multiple formats, including canning types, stripe types, satchel types, capsule types, tablet forms, and beverages, indicating a flexible manufacturing capability to support diverse customer needs.
In terms of market positioning, Hangzhou Nutrition Biotechnology Co., Ltd. highlights its reputation among prominent Chinese hospitals. Specifically, it mentions associations with institutions such as Peking Union Medical College Hospital, West China Hospital, The First Affiliated Hospital of Sun Yat-sen University, and The Second Affiliated Hospital of Zhejiang University School of Medicine. The stated market share of 15% within the medical foods segment suggests a measurable footprint in the sector, with a stated intention to sustain development and growth in the future. The company also notes its proximity to Shanghai, indicating logistical convenience given the approximately 1.5-hour drive from Shanghai Pudong International Airport, which may facilitate international shipments and supply chain operations.
Additional context provided by the company references collaborations with affiliate entities, including D-BASE and HILMAR MEIJI, as part of its corporate network. While specific details about these affiliations are not elaborated in detail, they imply an ecosystem of related entities that may contribute to product development, distribution, or regional market access. The overall narrative presents Hangzhou Nutrition Biotechnology Co., Ltd. as a research-oriented, quality-conscious producer of collagen-based products and enteral nutrition with domestic hospital relationships and international export potential. The combination of a defined production capacity, R&D emphasis, recognized certifications, and OEM capabilities positions the company within the biotechnical and nutritional product space with a focus on safety, quality, and market adaptability.
For potential partners or customers seeking collaboration in collagen products or enteral nutrition formulations, the company presents a profile that emphasizes technical capability, compliance with recognized standards, and a demonstrated ability to support customized manufacturing needs. The mention of hospital affiliations and a defined market share adds context to its potential credibility within the medical nutrition domain. Prospective inquiries may explore the breadth of OEM options and the extent of international distribution, given the company’s stated export orientation and logistical proximity to major Chinese and international hubs.
